Circulating miRNAs As Early Indicators of Diet and Physical Activity Response in Women With Metastatic Breast Cancer

References

• MariottoAB , EtzioniR , HurlbertM , PenberthyL , MayerM. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol. Biomarkers Prev.26(6), 809–815 (2017).
   PubMed Web of Science ®Google Scholar
• StebbingJ , CopsonE , O'ReillyS. Herceptin (trastuzamab) in advanced breast cancer. Cancer Treat. Rev.26(4), 287–290 (2000).
   PubMed Web of Science ®Google Scholar
• HortobagyiGN. Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer. Semin. Oncol.28(18 Suppl. 6), 43–47 (2001).
   PubMed Web of Science ®Google Scholar
• SwainSM , KimSB , CortesJet al.Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, Phase III study. Lancet Oncol.14(6), 461–471 (2013).
   PubMed Web of Science ®Google Scholar
• WaksAG , WinerEP. Breast cancer treatment: a review. JAMA321(3), 288–300 (2019).
   PubMed Web of Science ®Google Scholar
• IrvinWJr , MussHB , MayerDK. Symptom management in metastatic breast cancer. Oncologist16(9), 1203–1214 (2011).
   PubMed Web of Science ®Google Scholar
• SambiM , QorriB , HarlessW , SzewczukMR. Therapeutic options for metastatic breast cancer. Adv. Exp. Med. Biol.1152, 131–172 (2019).
   PubMed Web of Science ®Google Scholar
• EcclestoneC , ChowR , PulenzasNet al.Quality of life and symptom burden in patients with metastatic breast cancer. Support. Care Cancer24(9), 4035–4043 (2016).
   PubMed Web of Science ®Google Scholar
• GeorgeSM , IrwinML , SmithAWet al.Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control22(4), 589–598 (2011).
   PubMed Web of Science ®Google Scholar
• IzanoMA , FungTT , ChiuveSS , HuFB , HolmesMD. Are diet quality scores after breast cancer diagnosis associated with improved breast cancer survival?Nutr. Cancer65(6), 820–826 (2013).
   PubMed Web of Science ®Google Scholar
• RunowiczCD , LeachCR , HenryNLet al.American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J. Clin. Oncol.34(6), 611–635 (2016).
   PubMed Web of Science ®Google Scholar
• SpringfieldS , Odoms-YoungA , Tussing-HumphreysL , FreelsS , StolleyM. Adherence to American Cancer Society and American Institute of Cancer Research dietary guidelines in overweight African American breast cancer survivors. J. Cancer Surviv.13(2), 257–268 (2019).
   PubMed Web of Science ®Google Scholar
• PlaydonM , ThomasG , SanftT , HarriganM , LigibelJ , IrwinM. Weight loss intervention for breast cancer survivors: a systematic review. Curr. Breast Cancer Rep.5(3), 222–246 (2013).
   PubMedGoogle Scholar
• TravierN , BucklandG , VendrellJJet al.Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors. Eur. J. Cancer Care (Engl.)27(4), e12861 (2018).
   PubMed Web of Science ®Google Scholar
• ScruggsS , MamaSK , CarmackCL , DouglasT , DiamondP , Basen-EngquistK. Randomized Trial of a Lifestyle Physical Activity Intervention for Breast Cancer Survivors: Effects on Transtheoretical Model Variables. Health Promot. Pract.19(1), 134–144 (2018).
   PubMedGoogle Scholar
• StolleyM , SheeanP , GerberBet al.Efficacy of a weight loss intervention for african american breast cancer survivors. J. Clin. Oncol.35(24), 2820–2828 (2017).
   PubMed Web of Science ®Google Scholar
• AdamsBD , AremH , HubalMJet al.Exercise and weight loss interventions and miRNA expression in women with breast cancer. Breast Cancer Res. Treat.170(1), 55–67 (2018).
   PubMed Web of Science ®Google Scholar
• ZhangB , PanX , CobbGP , AndersonTA. microRNAs as oncogenes and tumor suppressors. Dev. Biol.302(1), 1–12 (2007).
   PubMed Web of Science ®Google Scholar
• IorioMV , CroceCM. microRNA involvement in human cancer. Carcinogenesis33(6), 1126–1133 (2012).
   PubMed Web of Science ®Google Scholar
• NassarFJ , NasrR , TalhoukR. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction. Pharmacol. Ther.172, 34–49 (2017).
   PubMed Web of Science ®Google Scholar
• BertoliG , CavaC , CastiglioniI. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics5(10), 1122–1143 (2015).
   PubMed Web of Science ®Google Scholar
• TeohSL , DasS. The role of micrornas in diagnosis, prognosis, metastasis and resistant cases in breast cancer. Curr. Pharm. Des.23(12), 1845–1859 (2017).
   PubMed Web of Science ®Google Scholar
• MoldovanL , BatteKE , TrgovcichJ , WislerJ , MarshCB , PiperM. Methodological challenges in utilizing miRNAs as circulating biomarkers. J. Cell. Mol. Med.18(3), 371–390 (2014).
   PubMed Web of Science ®Google Scholar
• MitchellPS , ParkinRK , KrohEMet al.Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA105(30), 10513–10518 (2008).
   PubMed Web of Science ®Google Scholar
• TomasikB , Chalubinska-FendlerJ , ChowdhuryD , FendlerW. Potential of serum microRNAs as biomarkers of radiation injury and tools for individualization of radiotherapy. Transl. Res.201, 71–83 (2018).
   PubMed Web of Science ®Google Scholar
• AbbasM , AhmedA , KhanGJet al.Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer. Curr. Probl. Cancer43(1), 5–17 (2019).
   PubMed Web of Science ®Google Scholar
• ZekriAN , El-SisiER , AbdallahZF , IsmailA , BarakatBarakat A. Gene expression profiling of circulating CD133(+) cells of hepatocellular carcinoma patients associated with HCV infection. J. Egypt Natl Canc. Inst.29(1), 19–24 (2017).
   PubMedGoogle Scholar
• VlachosIS , ZagganasK , ParaskevopoulouMDet al.DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res.43(W1), W460–466 (2015).
   PubMed Web of Science ®Google Scholar
• BabickiS , ArndtD , MarcuAet al.Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res.44(W1), W147–153 (2016).
   PubMed Web of Science ®Google Scholar
• PranavathiyaniG , ThanmalaganRR , LeimarembiDevi N , VenkatesanA. Integrated transcriptome interactome study of oncogenes and tumor suppressor genes in breast cancer. Genes Dis.6(1), 78–87 (2019).
   PubMed Web of Science ®Google Scholar
• GrosshansHK , FischerTT , SteinleJA , BrillAL , EhrlichBE. Neuronal Calcium Sensor 1 is up-regulated in response to stress to promote cell survival and motility in cancer cells. Mol. Oncol. doi:10.1002/1878-0261.12678 (2020) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• VanarsdaleT , BoshoffC , ArndtKT , AbrahamRT. Molecular pathways: targeting the cyclin D-CDK4/6 axis for cancer treatment. Clin. Cancer Res.21(13), 2905–2910 (2015).
   PubMed Web of Science ®Google Scholar
• LujanDA , OchoaJL , HartleyRS. Cold-inducible RNA binding protein in cancer and inflammation. Wiley Interdiscip. Rev. RNA9(2), Doi: 10.1002/wrna.1462 (2018).
   PubMed Web of Science ®Google Scholar
• KudinovAE , KaranicolasJ , GolemisEA , BoumberY. Musashi Rna-binding proteins as cancer drivers and novel therapeutic targets. Clin. Cancer Res.23(9), 2143–2153 (2017).
   PubMed Web of Science ®Google Scholar
• LortieG , SimoneauJA , HamelP , BoulayMR , LandryF , BouchardC. Responses of maximal aerobic power and capacity to aerobic training. Int. J. Sports Med.5(5), 232–236 (1984).
   PubMed Web of Science ®Google Scholar
• HammondBP , StotzPJ , BrennanAM , LamarcheB , DayAG , RossR. Individual variability in waist circumference and body weight in response to exercise. Med. Sci. Sports Exerc.51(2), 315–322 (2019).
   PubMed Web of Science ®Google Scholar
• HerreroP , RodríguezM , RasMR , DelPino A , ArolaL , CanelaN. Metabolomics analyses to investigate the role of diet and physical training. Methods Mol. Biol.1978, 403–430 (2019).
   PubMedGoogle Scholar
• HughesRL , KableME , MarcoM , KeimNL. The role of the gut microbiome in predicting response to diet and the development of precision nutrition models. Part II: results. Adv. Nutr.10(6), 979–998 (2019).
   PubMed Web of Science ®Google Scholar
• RossR , GoodpasterBH , KochLGet al.Precision exercise medicine: understanding exercise response variability. Br. J. Sports Med.53(18), 1141–1153 (2019).
   PubMed Web of Science ®Google Scholar
• MarkouA , YousefGM , StathopoulosE , GeorgouliasV , LianidouE. Prognostic significance of metastasis-related micrornas in early breast cancer patients with a long follow-up. Clin. Chem.60(1), 197–205 (2014).
   PubMed Web of Science ®Google Scholar
• HafezMM , HassanZK , ZekriARet al.MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pac. J. Cancer Prev.13(2), 591–598 (2012).
   PubMed Web of Science ®Google Scholar
• Avery-KiejdaKA , BrayeSG , MatheA , ForbesJF , ScottRJ. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer. BMC Cancer14, 51 (2014).
   PubMed Web of Science ®Google Scholar
• RothC , RackB , MüllerV , JanniW , PantelK , SchwarzenbachH. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res12(6), R90 (2010).
   PubMed Web of Science ®Google Scholar
• AhmadA , SethiS , ChenW , Ali-FehmiR , MittalS , SarkarFH. Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis. Am. J. Transl. Res.6(4), 384–390 (2014).
   PubMed Web of Science ®Google Scholar
• BozcukH , UsluG , SamurMet al.Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine27(2–3), 58–65 (2004).
   PubMed Web of Science ®Google Scholar
• PetekkayaI , UnluO , RoachECet al.Prognostic role of inflammatory biomarkers in metastatic breast cancer. J. BUON22(3), 614–622 (2017).
   PubMed Web of Science ®Google Scholar
• ZhangJ , RenL , YuMet al.S-equol inhibits proliferation and promotes apoptosis of human breast cancer MCF-7cells via regulating miR-10a-5p and PI3K/AKT pathway. Arch. Biochem. Biophys.672, 108064 (2019).
   PubMed Web of Science ®Google Scholar
• KimC , GoEJ , KimA. Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment. Biomarkers23(8), 804–811 (2018).
   PubMed Web of Science ®Google Scholar
• XiaoY , HumphriesB , YangC , WangZ. MiR-205 dysregulations in breast cancer: the complexity and opportunities. Noncoding RNA5(4), 53 (2019).
   PubMed Web of Science ®Google Scholar
• KimES , ChoiJY , HwangSJ , BaeIH. Hypermethylation of miR-205-5p by IR governs aggressiveness and metastasis via regulating Bcl-w and Src. Mol. Ther. Nucleic. Acids.14, 450–464 (2019).
   PubMedGoogle Scholar
• StankevicinsL , BaratA , DessenP , VassetzkyY , DeMoura Gallo CV. The microRNA-205-5p is correlated to metastatic potential of 21T series: a breast cancer progression model. PLoS ONE12(3), e0173756 (2017).
   PubMed Web of Science ®Google Scholar
• DeCola A , VolpeS , BudaniMCet al.miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. Cell Death Dis.6, e1823 (2015).
   PubMed Web of Science ®Google Scholar
• CalvanoFilho CM , Calvano-MendesDC , CarvalhoKCet al.Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p. Tumour Biol.35(8), 7733–7741 (2014).
   PubMedGoogle Scholar
• MaC , ShiX , GuoW , FengF , WangG. miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation. Exp. Ther. Med.18(5), 3525–3533 (2019).
   PubMed Web of Science ®Google Scholar
• ZhangH , LiB , ZhaoH , ChangJ. The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers. Int. J. Clin. Exp. Med.8(2), 3034–3043 (2015).
   PubMed Web of Science ®Google Scholar
• YangY , XunN , WuJG. Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p. Eur. Rev. Med. Pharmacol Sci.23(16), 6971–6982 (2019).
   PubMed Web of Science ®Google Scholar
• DeCola A , LamolinaraA , LanutiPet al.MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells. Cell Death Dis.9(8), 821 (2018).
   PubMedGoogle Scholar
• HuoD , ClaytonWM , YoshimatsuTF , ChenJ , OlopadeOI. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients. Oncotarget7(34), 55231–55248 (2016).
   PubMedGoogle Scholar
• ChenLL , ZhangZJ , YiZB , LiJJ. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. Br. J. Cancer117(1), 78–88 (2017).
   PubMed Web of Science ®Google Scholar
• YarahmadiS , AbdolvahabiZ , HesariZet al.Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Gene711, 143939 (2019).
   PubMed Web of Science ®Google Scholar
• Picon-RuizM , Morata-TarifaC , Valle-GoffinJJ , FriedmanER , SlingerlandJM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J. Clin.67(5), 378–397 (2017).
   PubMed Web of Science ®Google Scholar
• GoodwinPJ , AmbrosoneCB , HongCC. Modifiable lifestyle factors and breast cancer outcomes: current controversies and research recommendations. Adv. Exp. Med. Biol.862, 177–192 (2015).
   PubMed Web of Science ®Google Scholar
• Demark-WahnefriedW , RogersLQ , GibsonJTet al.Randomized trial of weight loss in primary breast cancer: impact on body composition, circulating biomarkers and tumor characteristics. Int. J. Cancer doi:10.1002/ijc.32637 (2019) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• SedlacekSM , PlaydonMC , WolfePet al.Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients (‘CHOICE’): study protocol. BMC Cancer11, 287 (2011).
   PubMed Web of Science ®Google Scholar
• UnverN , McallisterF. IL-6 family cytokines: key inflammatory mediators as biomarkers and potential therapeutic targets. Cytokine Growth Factor Rev.41, 10–17 (2018).
   PubMed Web of Science ®Google Scholar
• MatsuokaJ , KunitomiT , NishizakiM , IwamotoT , KatayamaH. Advance care planning in metastatic breast cancer. Chin. Clin. Oncol.7(3), 33 (2018).
   PubMedGoogle Scholar
• VlachosIS , ZagganasK , ParaskevopoulouMDet al.DIANA-miRPath v3. 0: deciphering microRNA function with experimental support. Nucleic Acids Res.43(W1), W460–W466 (2015).
   PubMed Web of Science ®Google Scholar